Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy

BACKGROUND: In view of the fast viremia decline obtained with integrase inhibitors, we studied the respective effects of initiating efavirenz (EFV) or raltegravir (RAL)-based antiretroviral therapy (ART) regimens on human immunodeficiency virus (HIV)-1 deoxyribonucleic acid (DNA) levels and inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Delagreverie, Héloïse M, Bauduin, Claire, De Castro, Nathalie, Grinsztejn, Beatriz, Chevrier, Marc, Jouenne, Fanélie, Mourah, Samia, Kalidi, Issa, Pilotto, Jose Henrique, Brites, Carlos, Tregnago Barcellos, Nemora, Amara, Ali, Wittkop, Linda, Molina, Jean-Michel, Delaugerre, Constance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019658/
https://www.ncbi.nlm.nih.gov/pubmed/32083147
http://dx.doi.org/10.1093/ofid/ofz549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019658/
https://www.ncbi.nlm.nih.gov/pubmed/32083147
http://dx.doi.org/10.1093/ofid/ofz549

Ejemplares similares